Impact of poor performance status of the treatment of small cell lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 394s Year: 2001
Socioeconomic deprivation as a poor prognostic factor in small cell lung cancer (SCLC) Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009
Effects of integrated care on lung function and health status in COPD patients Source: Annual Congress 2004 - Burden of obstructive lung diseases: costs, mortality and life impairment Year: 2004
Prognostic value of smoking status in operated non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 40s Year: 2004
Lung cancer and socioeconomic status: Differences in demographics, stage, treatment and mortality in a lung cancer centre Source: International Congress 2015 – Quality management in lung cancer Year: 2015
Survey on health system aspects concerning malignant diseases (lung cancer) in limited health resources country Source: Annual Congress 2008 - Various aspects of thoracic oncology Year: 2008
Chemotherapy improves low performance status lung cancer patients Source: Eur Respir J 2007; 30: 1186-1192 Year: 2007
Performance status as predictor factor of quality of life in patients with non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 75s Year: 2004
The effect of nutritional indicators on prognosis of patients with advanced lung cancer Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology Year: 2019
Delays in lung cancer management Source: Annual Congress 2005 - Management of lung cancer: clinical problems Year: 2005
Real-world treatment patterns and outcomes of patients with extensive disease small cell lung cancer (ED SCLC) Source: International Congress 2019 – Treatment of lung cancer Year: 2019
Biomarkers for non-small cell lung cancer (NSCLC) treatment: examples and unmet needs, a clinical perspective Source: International Congress 2014 – From bench to bedside: biomarkers and biobanking for lung cancer in 2014 Year: 2014
Symptom control in advanced non-small cell lung cancer (NSCLC): what is the influence of cisplatin-use, age, performance status and duration of chemotherapy? Analysis of a randomized database Source: Eur Respir J 2002; 20: Suppl. 38, 596s Year: 2002
Patient-reported outcome measures: do they improve the quality of supportive care in advanced non-small cell lung cancer? Source: Virtual Congress 2021 – Therapy of lung cancer Year: 2021
Correlation of quality of life parameters with parameters of health state in patients with nonsmall cell lung cancer treated by chemotherapy Source: Eur Respir J 2003; 22: Suppl. 45, 30s Year: 2003
The prognostic impact of stage and performance status on surgically resected non-small cell lung cancer Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012
Is smoking status a prognostic factor in resected lung cancer? Source: ISSN=ISSN 1810-6838, ISBN=, page=78 Year: 2006
Holistic needs assessment (HNA) in lung cancer patients; bridging health and social care Source: International Congress 2018 – The many facets of respiratory nursing Year: 2018
Attempting tissue diagnosis in performance status 3 and 4 lung cancer patients may not influence treatment or survival Source: Annual Congress 2013 –Quality management in thoracic oncology Year: 2013
Comparing the use and timing of palliative care services in COPD and lung cancer: a population-based survey Source: Eur Respir J, 51 (5) 1702405; 10.1183/13993003.02405-2017 Year: 2018